434 related articles for article (PubMed ID: 25480017)
1. Investigating the antifungal activity and mechanism(s) of geraniol against Candida albicans strains.
Leite MC; de Brito Bezerra AP; de Sousa JP; de Oliveira Lima E
Med Mycol; 2015 Apr; 53(3):275-84. PubMed ID: 25480017
[TBL] [Abstract][Full Text] [Related]
2. Antifungal activity of geraniol and citronellol, two monoterpenes alcohols, against Trichophyton rubrum involves inhibition of ergosterol biosynthesis.
Pereira Fde O; Mendes JM; Lima IO; Mota KS; Oliveira WA; Lima Ede O
Pharm Biol; 2015 Feb; 53(2):228-34. PubMed ID: 25414073
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of anti-Candida potential of geranium oil constituents against clinical isolates of Candida albicans differentially sensitive to fluconazole: inhibition of growth, dimorphism and sensitization.
Zore GB; Thakre AD; Rathod V; Karuppayil SM
Mycoses; 2011 Jul; 54(4):e99-109. PubMed ID: 20337938
[TBL] [Abstract][Full Text] [Related]
4. Anti-Candida albicans effectiveness of citral and investigation of mode of action.
Lima IO; de Medeiros Nóbrega F; de Oliveira WA; de Oliveira Lima E; Albuquerque Menezes E; Cunha FA; Formiga Melo Diniz Mde F
Pharm Biol; 2012 Dec; 50(12):1536-41. PubMed ID: 23116193
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Antifungal Activity and Mechanism of Action of Citral against Candida albicans.
Leite MC; Bezerra AP; de Sousa JP; Guerra FQ; Lima Ede O
Evid Based Complement Alternat Med; 2014; 2014():378280. PubMed ID: 25250053
[TBL] [Abstract][Full Text] [Related]
6. Anti-Candida activity of geraniol involves disruption of cell membrane integrity and function.
Sharma Y; Khan LA; Manzoor N
J Mycol Med; 2016 Sep; 26(3):244-54. PubMed ID: 27554866
[TBL] [Abstract][Full Text] [Related]
7. The possible mechanism of rhapontigenin influencing antifungal activity on Candida albicans.
Kim N; Kim JK; Hwang D; Lim YH
Med Mycol; 2013 Jan; 51(1):45-52. PubMed ID: 22662760
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of terpenes against Candida albicans and ultrastructural alterations.
Martínez A; Rojas N; García L; González F; Domínguez M; Catalán A
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Nov; 118(5):553-9. PubMed ID: 25442491
[TBL] [Abstract][Full Text] [Related]
10. Fungicidal effect of three new synthetic cationic peptides against Candida albicans.
Nikawa H; Fukushima H; Makihira S; Hamada T; Samaranayake LP
Oral Dis; 2004 Jul; 10(4):221-8. PubMed ID: 15196144
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the inhibitory effect of voriconazole on the fungicidal activity of amphotericin B against Candida albicans in an in vitro kinetic model.
Lignell A; Löwdin E; Cars O; Sjölin J
J Antimicrob Chemother; 2008 Jul; 62(1):142-8. PubMed ID: 18408237
[TBL] [Abstract][Full Text] [Related]
12. Mode of action and synergistic effect of valinomycin and cereulide with amphotericin B against Candida albicans and Cryptococcus albidus.
Makarasen A; Reukngam N; Khlaychan P; Chuysinuan P; Isobe M; Techasakul S
J Mycol Med; 2018 Mar; 28(1):112-121. PubMed ID: 29276078
[TBL] [Abstract][Full Text] [Related]
13. Antifungal mechanisms supporting boric acid therapy of Candida vaginitis.
De Seta F; Schmidt M; Vu B; Essmann M; Larsen B
J Antimicrob Chemother; 2009 Feb; 63(2):325-36. PubMed ID: 19059942
[TBL] [Abstract][Full Text] [Related]
14. Antifungal potential of Sideroxylon obtusifolium and Syzygium cumini and their mode of action against Candida albicans.
Pereira JV; Freires IA; Castilho AR; da Cunha MG; Alves Hda S; Rosalen PL
Pharm Biol; 2016 Oct; 54(10):2312-9. PubMed ID: 26987037
[TBL] [Abstract][Full Text] [Related]
15. [Antifungal activity of melanin in clinical isolates of Candida spp].
Fuentes M; Hernández R; Gordillo D; Amaro J; Falconer MA; Alburquenque C; Tapia CV
Rev Chilena Infectol; 2014 Feb; 31(1):28-33. PubMed ID: 24740771
[TBL] [Abstract][Full Text] [Related]
16. Synergistic and drug-resistant reversing effects of diorcinol D combined with fluconazole against Candida albicans.
Li Y; Chang W; Zhang M; Li X; Jiao Y; Lou H
FEMS Yeast Res; 2015 Mar; 15(2):. PubMed ID: 25752309
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of in vitro activity of carvacrol against Candida albicans strains.
Vardar-Unlu G; Yağmuroğlu A; Unlu M
Nat Prod Res; 2010 Jul; 24(12):1189-93. PubMed ID: 20582812
[TBL] [Abstract][Full Text] [Related]
18. Antifungal activity of 4-hydroxy-3-(3-methyl-2-butenyl)acetophenone against Candida albicans: evidence for the antifungal mode of action.
Soberón JR; Lizarraga EF; Sgariglia MA; Carrasco Juárez MB; Sampietro DA; Ben Altabef A; Catalán CA; Vattuone MA
Antonie Van Leeuwenhoek; 2015 Nov; 108(5):1047-57. PubMed ID: 26342699
[TBL] [Abstract][Full Text] [Related]
19. Antifungal activity of coronarin D against Candida albicans.
Kaomongkolgit R; Jamdee K; Wongnoi S; Chimnoi N; Techasakul S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Jul; 114(1):61-6. PubMed ID: 22727093
[TBL] [Abstract][Full Text] [Related]
20. Approaches to the mechanism of antifungal activity of Zuccagnia punctata-Larrea nitida bi-herbal combination.
Butassi E; Svetaz LA; Sortino MA; Quiroga AD; Carvalho VSD; Cortés JCG; Ribas JC; Zacchino SA
Phytomedicine; 2019 Feb; 54():291-301. PubMed ID: 30668380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
